Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

56%

5 of 9 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A
8(61.5%)
Phase 2
3(23.1%)
Phase 3
1(7.7%)
Phase 4
1(7.7%)
13Total
N/A(8)
Phase 2(3)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded